Literature DB >> 24686168

Distinguishing between benign and malignant melanocytic nevi by in vivo multiphoton microscopy.

Mihaela Balu1, Kristen M Kelly1, Christopher B Zachary1, Ronald M Harris1, Tatiana B Krasieva1, Karsten König2, Anthony J Durkin1, Bruce J Tromberg3.   

Abstract

Monitoring of atypical nevi is an important step in early detection of melanoma, a clinical imperative in preventing the disease progression. Current standard diagnosis is based on biopsy and histopathologic examination, a method that is invasive and highly dependent upon physician experience. In this work, we used a clinical multiphoton microscope to image in vivo and noninvasively melanocytic nevi at three different stages: common nevi without dysplastic changes, dysplastic nevi with structural and architectural atypia, and melanoma. We analyzed multiphoton microscopy (MPM) images corresponding to 15 lesions (five in each group) both qualitatively and quantitatively. For the qualitative analysis, we identified the morphologic features characteristic of each group. MPM images corresponding to dysplastic nevi and melanoma were compared with standard histopathology to determine correlations between tissue constituents and morphology and to evaluate whether standard histopathology criteria can be identified in the MPM images. Prominent qualitative correlations included the morphology of epidermal keratinocytes, the appearance of nests of nevus cells surrounded by collagen fibers, and the structure of the epidermal-dermal junction. For the quantitative analysis, we defined a numerical multiphoton melanoma index (MMI) based on three-dimensional in vivo image analysis that scores signals derived from two-photon excited fluorescence, second harmonic generation, and melanocyte morphology features on a continuous 9-point scale. Indices corresponding to common nevi (0-1), dysplastic nevi (1-4), and melanoma (5-8) were significantly different (P < 0.05), suggesting the potential of the method to distinguish between melanocytic nevi in vivo. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24686168      PMCID: PMC4024350          DOI: 10.1158/0008-5472.CAN-13-2582

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Pump-probe imaging differentiates melanoma from melanocytic nevi.

Authors:  Thomas E Matthews; Ivan R Piletic; M Angelica Selim; Mary Jane Simpson; Warren S Warren
Journal:  Sci Transl Med       Date:  2011-02-23       Impact factor: 17.956

2.  False negative clinical diagnoses of malignant melanoma.

Authors:  J E Osborne; J F Bourke; R A Graham-Brown; P E Hutchinson
Journal:  Br J Dermatol       Date:  1999-05       Impact factor: 9.302

3.  Two-photon excited fluorescence lifetime imaging and spectroscopy of melanins in vitro and in vivo.

Authors:  Tatiana B Krasieva; Chiara Stringari; Feng Liu; Chung-Ho Sun; Yu Kong; Mihaela Balu; Frank L Meyskens; Enrico Gratton; Bruce J Tromberg
Journal:  J Biomed Opt       Date:  2013-03       Impact factor: 3.170

4.  Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo.

Authors:  R G Langley; M Rajadhyaksha; P J Dwyer; A J Sober; T J Flotte; R R Anderson
Journal:  J Am Acad Dermatol       Date:  2001-09       Impact factor: 11.527

5.  Comparison of diagnostic accuracy for cutaneous malignant melanoma between general dermatology, plastic surgery and pigmented lesion clinics.

Authors:  J E Osborne; T A Chave; P E Hutchinson
Journal:  Br J Dermatol       Date:  2003-02       Impact factor: 9.302

Review 6.  Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.

Authors:  Naheed R Abbasi; Helen M Shaw; Darrell S Rigel; Robert J Friedman; William H McCarthy; Iman Osman; Alfred W Kopf; David Polsky
Journal:  JAMA       Date:  2004-12-08       Impact factor: 56.272

7.  Sensitivity and specificity of multiphoton laser tomography for in vivo and ex vivo diagnosis of malignant melanoma.

Authors:  Enrico Dimitrow; Mirjana Ziemer; Martin Johannes Koehler; Johannes Norgauer; Karsten König; Peter Elsner; Martin Kaatz
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

8.  Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.

Authors:  H K Koh; L A Norton; A C Geller; T Sun; D S Rigel; D R Miller; R G Sikes; K Vigeland; E U Bachenberg; P A Menon; S F Billon; G Goldberg; D A Scarborough; W M Ramsdell; V A Muscarella; R A Lew
Journal:  J Am Acad Dermatol       Date:  1996-06       Impact factor: 11.527

9.  Final version of 2009 AJCC melanoma staging and classification.

Authors:  Charles M Balch; Jeffrey E Gershenwald; Seng-Jaw Soong; John F Thompson; Michael B Atkins; David R Byrd; Antonio C Buzaid; Alistair J Cochran; Daniel G Coit; Shouluan Ding; Alexander M Eggermont; Keith T Flaherty; Phyllis A Gimotty; John M Kirkwood; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Arthur J Sober; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more
  45 in total

1.  Translational label-free nonlinear imaging biomarkers to classify the human corneal microstructure.

Authors:  Marco Lombardo; David Merino; Pablo Loza-Alvarez; Giuseppe Lombardo
Journal:  Biomed Opt Express       Date:  2015-07-08       Impact factor: 3.732

2.  Effect of recombinant interleukin-12 on murine skin regeneration and cell dynamics using in vivo multimodal microscopy.

Authors:  Joanne Li; Andrew J Bower; Vladimir Vainstein; Zoya Gluzman-Poltorak; Eric J Chaney; Marina Marjanovic; Lena A Basile; Stephen A Boppart
Journal:  Biomed Opt Express       Date:  2015-10-06       Impact factor: 3.732

3.  In vivo multiphoton microscopy of melasma.

Authors:  Griffin Lentsch; Mihaela Balu; Joshua Williams; Sanghoon Lee; Ronald M Harris; Karsten König; Anand Ganesan; Bruce J Tromberg; Nirmala Nair; Uma Santhanam; Manoj Misra
Journal:  Pigment Cell Melanoma Res       Date:  2018-12-21       Impact factor: 4.693

4.  Rapid staining and imaging of subnuclear features to differentiate between malignant and benign breast tissues at a point-of-care setting.

Authors:  Jenna L Mueller; Jennifer E Gallagher; Rhea Chitalia; Marlee Krieger; Alaattin Erkanli; Rebecca M Willett; Joseph Geradts; Nimmi Ramanujam
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-22       Impact factor: 4.553

Review 5.  [Multiphoton tomography].

Authors:  M Zieger; S Springer; M J Koehler; M Kaatz
Journal:  Hautarzt       Date:  2015-07       Impact factor: 0.751

6.  Comparing in vivo pump-probe and multiphoton fluorescence microscopy of melanoma and pigmented lesions.

Authors:  Jesse W Wilson; Simone Degan; Christina S Gainey; Tanya Mitropoulos; Mary Jane Simpson; Jennifer Y Zhang; Warren S Warren
Journal:  J Biomed Opt       Date:  2015-05       Impact factor: 3.170

7.  Multipurpose nonlinear optical imaging system for in vivo and ex vivo multimodal histology.

Authors:  Martin Weinigel; Hans Georg Breunig; Aisada Uchugonova; Karsten König
Journal:  J Med Imaging (Bellingham)       Date:  2015-03-04

8.  Rapid mesoscale multiphoton microscopy of human skin.

Authors:  Mihaela Balu; Hideharu Mikami; Jue Hou; Eric O Potma; Bruce J Tromberg
Journal:  Biomed Opt Express       Date:  2016-10-03       Impact factor: 3.732

9.  Handheld nonlinear microscope system comprising a 2 MHz repetition rate, mode-locked Yb-fiber laser for in vivo biomedical imaging.

Authors:  Ádám Krolopp; Attila Csákányi; Dóra Haluszka; Dániel Csáti; Lajos Vass; Attila Kolonics; Norbert Wikonkál; Róbert Szipőcs
Journal:  Biomed Opt Express       Date:  2016-08-19       Impact factor: 3.732

10.  Frontiers in Intravital Multiphoton Microscopy of Cancer.

Authors:  Louisiane Perrin; Battuya Bayarmagnai; Bojana Gligorijevic
Journal:  Cancer Rep (Hoboken)       Date:  2019-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.